Cargando…

Prediction of Adeno-Associated Virus Neutralizing Antibody Activity for Clinical Application

Patients with neutralizing antibodies (Nab) against adeno-associated virus (AAV) are usually excluded from treatment with AAV vectors. To develop a standard assay for detecting Nab inhibition activity, we systematically studied current AAV Nab assays in vitro and in vivo. Several factors were found...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mei, Crosby, Ashley, Hastie, Eric, Samulski, Jade J., McPhee, Scott, Joshua, Grieger, Samulski, R. Jude, Li, Chengwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670282/ https://www.ncbi.nlm.nih.gov/pubmed/26125606 http://dx.doi.org/10.1038/gt.2015.69

Ejemplares similares

Employing a Gain-of-Function Factor IX Variant R338L to Advance the Efficacy and Safety of Hemophilia B Human Gene Therapy: Preclinical Evaluation Supporting an Ongoing Adeno-Associated Virus Clinical Trial
por: Monahan, Paul E., et al.
Publicado: (2015)

Adeno-Associated Virus (AAV) Versus Immune Response
por: Rabinowitz, Joseph, et al.
Publicado: (2019)

Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors
por: Chai, Zheng, et al.
Publicado: (2019)

Efficient Capsid Antigen Presentation From Adeno-Associated Virus Empty Virions In Vivo
por: Pei, Xiaolei, et al.
Publicado: (2018)

Corrigendum: Efficient Capsid Antigen Presentation From Adeno-Associated Virus Empty Virions In Vivo
por: Pei, Xiaolei, et al.
Publicado: (2020)

Self-complementarity in adeno-associated virus enhances transduction and gene expression in mouse cochlear tissues
por: Casey, Graham, et al.
Publicado: (2020)

Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice
por: Ye, Lei, et al.
Publicado: (2015)

Direct Interaction of Human Serum Proteins with AAV Virions to Enhance AAV Transduction: Immediate Impact on Clinical Applications
por: Wang, Mei, et al.
Publicado: (2016)

Superior human hepatocyte transduction with Adeno-associated Virus Vector Serotype 7
por: Shao, Wenwei, et al.
Publicado: (2019)

Satellite Subgenomic Particles Are Key Regulators of Adeno-Associated Virus Life Cycle
por: Zhang, Junping, et al.
Publicado: (2021)

Biology of adeno-associated viral vectors in the central nervous system
por: Murlidharan, Giridhar, et al.
Publicado: (2014)

Adeno-Associated Viral Vectors Show Serotype Specific Transduction of Equine Joint Tissue Explants and Cultured Monolayers
por: Hemphill, Daniel D., et al.
Publicado: (2014)

Global CNS Gene Delivery and Evasion of Anti-AAV Neutralizing Antibodies by Intrathecal AAV Administration in Non-Human Primates
por: Gray, Steven J., et al.
Publicado: (2013)

Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity
por: Pei, Xiaolei, et al.
Publicado: (2020)

AAV Recombineering with Single Strand Oligonucleotides
por: Hirsch, Matthew L., et al.
Publicado: (2009)

Gene therapy approaches for equine osteoarthritis
por: Thampi, Parvathy, et al.
Publicado: (2022)

Corrigendum: Gene therapy approaches for equine osteoarthritis
por: Thampi, Parvathy, et al.
Publicado: (2023)

Complement Activation by Adeno-Associated Virus-Neutralizing Antibody Complexes
por: West, Cara, et al.
Publicado: (2023)

Creating a Novel Origin of Replication through Modulating DNA-Protein Interfaces
por: Hewitt, F. Curtis, et al.
Publicado: (2010)

Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Efficacy
por: Bartus, Raymond T, et al.
Publicado: (2014)

Optimization of scAAVIL-1ra In Vitro and In Vivo to Deliver High Levels of Therapeutic Protein for Treatment of Osteoarthritis
por: Goodrich, Laurie R, et al.
Publicado: (2013)

Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
por: Large, Edward E., et al.
Publicado: (2023)

β-Cell–Specific IL-2 Therapy Increases Islet Foxp3(+)Treg and Suppresses Type 1 Diabetes in NOD Mice
por: Johnson, Mark C., et al.
Publicado: (2013)

Manufacturing of recombinant adeno-associated viral vectors for clinical trials
por: Clément, Nathalie, et al.
Publicado: (2016)

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs
por: Kashiwakura, Yuji, et al.
Publicado: (2022)

Preexposure and Postexposure Prophylaxis of Rabies With Adeno-Associated Virus Expressing Virus-Neutralizing Antibody in Rodent Models
por: Huang, Fei, et al.
Publicado: (2021)

Chimeric Mice Engrafted With Canine Hepatocytes Exhibits Similar AAV Transduction Efficiency to Hemophilia B Dog
por: Shao, Wenwei, et al.
Publicado: (2022)

Sub-2 Å Ewald curvature corrected structure of an AAV2 capsid variant
por: Tan, Yong Zi, et al.
Publicado: (2018)

Safety and biodistribution assessment of sc-rAAV2.5IL-1Ra administered via intra-articular injection in a mono-iodoacetate-induced osteoarthritis rat model
por: Wang, Gensheng, et al.
Publicado: (2016)

Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with an In Vitro Reporter System
por: Meliani, Amine, et al.
Publicado: (2015)

Adeno-Associated Virus Neutralizing Antibodies in Large Animals and Their Impact on Brain Intraparenchymal Gene Transfer
por: Wang, Dan, et al.
Publicado: (2018)

Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies
por: Li, Ya, et al.
Publicado: (2019)

Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1
por: Lin, Allen, et al.
Publicado: (2018)

Modifiers of Adeno-Associated Virus-Mediated Gene Expression in Implication for Serotype-Universal Neutralizing Antibody Assay
por: Krotova, Karina, et al.
Publicado: (2020)

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies
por: Demminger, Daniel E, et al.
Publicado: (2020)

Relationship Between Neutralizing Antibodies Against Adeno-Associated Virus in the Vitreous and Serum: Effects on Retinal Gene Therapy
por: Lee, Suhwan, et al.
Publicado: (2019)

Adeno-associated virus-binding antibodies detected in cats living in the Northeastern United States lack neutralizing activity
por: Adachi, Kei, et al.
Publicado: (2020)

Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays
por: Butala-Flores, Elizabeth, et al.
Publicado: (2023)

Preclinical toxicity evaluation of AAV for pain: evidence from human AAV studies and from the pharmacology of analgesic drugs
por: Pleticha, Josef, et al.
Publicado: (2014)

The cytopathologic features of mammary analog secretory carcinoma and its mimics
por: Samulski, T. Danielle, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_na5h66oeimob9d36l0utvucpdl